NCT04318210View on ClinicalTrials.gov

Open Label Extension (OLE) of the TDF2 Study, Botswana

NACompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
HIV Infections
Interventions
DRUG

Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

All Listed Sponsors
collaborator

Botswana Ministry of Health

OTHER_GOV

lead

Centers for Disease Control and Prevention

FED

NCT04318210 - Open Label Extension (OLE) of the TDF2 Study, Botswana | Biotech Hunter | Biotech Hunter